Jupiter Neurosciences earnings were -$5.9M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest JUNS earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$2.3M, up 47.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, JUNS reported annual earnings of -$2.4M, with -49% growth. The next JUNS earnings date is Dec 3, 2025.
Jupiter Neurosciences Earnings Reports & History FAQ
What were Jupiter Neurosciences's earnings last quarter?
On JUNS's earnings call on Invalid Date, Jupiter Neurosciences (NASDAQ: JUNS) reported Q2 2025 earnings per share (EPS) of -$0.07, up 800% year over year. Total JUNS earnings for the quarter were -$2.25 million. In the same quarter last year, Jupiter Neurosciences's earnings per share (EPS) was $0.01.
The next JUNS earnings call is Invalid Date. Add JUNS to your watchlist to be reminded of Jupiter Neurosciences's next earnings date.
Is Jupiter Neurosciences profitable or losing money?
As of the last Jupiter Neurosciences earnings report, Jupiter Neurosciences is currently losing money. Jupiter Neurosciences's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$5.90 million, a 133.7% increase year over year.
What was JUNS's earnings growth in the past year?
As of Jupiter Neurosciences's earnings date in Invalid Date, Jupiter Neurosciences's earnings has grown year over year. JUNS earnings in the past year totalled -$5.90 million.
What are Jupiter Neurosciences's earnings expectations?
The current EPS estimate for Jupiter Neurosciences's earnings report in Invalid Date is -$0.08.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.